Synnovation Therapeutics
Jeffrey Yang has a diverse work experience spanning multiple organizations. Jeffrey is currently employed as an Associate Director at Synnovation Therapeutics since August 2021. Prior to this, they worked at Incyte as a Senior Research Investigator from June 2018 to July 2021. From July 2014 to June 2018, they were a Graduate Research Assistant at the Massachusetts Institute of Technology (MIT). Additionally, they worked as a Research Assistant Intern at Pfizer from September 2016 to January 2017. Jeffrey'searlier experience includes being a Research Assistant at the University of Washington from August 2011 to June 2014, where they worked under the guidance of Alex K. Y. Jen. Jeffrey also served as an Undergraduate Research Assistant at the same university from March 2010 to July 2011.
Jeffrey Yang earned their Bachelor of Science (B.S.) degree in Biochemistry and Chemistry from the University of Washington between 2007 and 2011. Jeffrey then pursued further education at the Massachusetts Institute of Technology from 2014 to 2018, where they obtained their Doctor of Philosophy (PhD) degree in Organic Chemistry.
This person is not in any teams
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.